Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
Recruiting · NCT05820919 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Alabama, Tuscaloosa
View the official record on ClinicalTrials.gov →Interventions studied
LOCK Sleep ProgramNo intervention (control period/baseline data collection)
What this trial is about
This study seeks to improve clinical outcomes for an important, growing, and vulnerable population-nursing home residents with Alzheimer's disease or related dementias-by testing an evidence-based intervention to improve these residents' sleep. It will also examine the implementation and sustainment of this intervention.
Who can take part
Age range
50 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Nursing home residents aged \>=50 years with an Alzheimer disease or related dementia (ADRD) diagnosis, identified by nursing home staff participating in frontline LOCK sleep huddles as having sleep problems
Exclusion criteria
- Residents with a high risk of OSA who are not being treated for OSA because actigraph measurements are inaccurate in that population.
- Residents who have a persistent bilateral resting tremor or paralysis in both arms (a subset of persons with Parkinson's disease and related significant tremor-causing diagnoses), due to actigraph measurement inaccuracies
Where it is running
3 locations listed across 3 US states.
- Vivage/Beecan Corporation - Lakewood, Colorado, United States
- National HealthCare Corporation - Murfreesboro, Tennessee, United States
- Caraday Healthcare, LLC - San Marcos, Texas, United States